News and Events
Combining bevacizumab with erlotinib shrinks tumors in patients with rare and aggressive kidney cancer
Seventy-two percent of patients with HLRCC-associated kidney cancers, for which there previously was no known drug treatment, responded to the therapy in a clinical trial.
Read More
Drug shrinks nerve tumors in adults with neurofibromatosis type 1 in a clinical trial
Until recently, no effective treatments existed for non-cancerous inoperable nerve tumors, called plexiform neurofibroma, in adults. A clinical trial of the drug selumetinib shows it can cause tumor shrinkage and relieve symptoms, such as pain.
Read More
Celebrating CCR Careers: Jay A. Berzofsky, M.D., Ph.D.
Jay A. Berzofsky, M.D., Ph.D., a chemist-turned-immunologist who pioneered cancer immunology and immunotherapy strategies, announces his retirement from the NCI.
Read More
Empowering others to contribute to rare neuroendocrine tumor research
Lacey Koelling was diagnosed with paraganglioma tumors in 2018, which began to metastasize five years later. She enrolled in an NIH trial to contribute to research on this rare cancer.
Read More
An observant patient opens new doors for cancer screening
David Drash enrolled in a CCR clinical trial when he was diagnosed with BAP1 tumor predisposition syndrome (TPDS) in 2022. He noticed that everyone in his family with BAP1 TPDS had white lines on their fingernails; his observation led to the discovery of a new detection tool.
Read More
Celebrating CCR Careers: Alan Rein, Ph.D.
Alan Rein, Ph.D., is a known expert in the field of viral assembly, particularly in retroviruses like the human immunodeficiency virus (HIV). After an extensive career studying molecular mechanisms of retroviral replication and pathogenesis, he has announced his retirement.
Read More
Clinical trial researching MRI software for mapping prostate cancer
A clinical trial led by Ismail Baris Turkbey, M.D., Senior Clinician in the Molecular Imaging Branch, is researching a software that can analyze radiographic images of the prostate for cancer detection and diagnosis.
Read More
Mutant RAS can shift other proteins’ positions inside cancer cells
Mutant RAS proteins help shuttle other proteins out of the cell nucleus and into the cytoplasm, where some can promote cancerous growth.
Read More
Clinical trial researching combination drug therapy for Ewing sarcoma and rhabdomyosarcoma
A clinical trial led by Christine M. Heske, M.D., Investigator in the Pediatric Oncology Branch, is researching combination drug therapy for adolescents and young adults with Ewing sarcoma and rhabdomyosarcoma.
Read More
Clinical trial researching drug therapy for adults with colorectal or gastroesophageal cancer
A clinical trial led by Nicholas D. Klemen, M.D., Physician-Scientist Early Investigator in the Surgery Branch, is researching drug therapy for adults with colorectal or gastroesophageal cancer.
Read More
Clinical trial researching drug therapy for adults with HIV-related diseases
A clinical trial led by Ramya Ramaswami, M.B.B.S., M.P.H., Lasker Clinical Research Scholar in the HIV and AIDS Malignancy Branch, is researching drug therapy for two HIV-related diseases.
Read More